The 2019 online pre-exposure prophylaxis (PrEP) user survey in the United Kingdom was conducted to assess HIV PrEP access, and user characteristics. One in five respondents continued experiencing difficulties accessing PrEP; users were almost exclusively gay or bisexual men at high risk of HIV. The majority obtained PrEP through health service clinics and rated PrEP positively. High STI rates were reported among users. Renal and sexual health checks are advised for those sourcing PrEP privately.
Pre-exposure prophylaxis (PrEP) has been available in the United Kingdom (UK) through online purchase since Autumn 2015, National Health Service (NHS)-funded programmes via sexual health clinics in Scotland and Wales since July 2017, a health service funded trial in England since October 2017 and a risk reduction clinic in Northern Ireland since July 2018. We conducted an online survey to assess PrEP access in the UK, to capture experiences of people living in the UK who are using or report being unable to obtain PrEP since January 2017, and to estimate an upper limit of the number of current users in the UK.
Survey population
For this survey, a current PrEP user was defined as someone reporting to have taken their first PrEP tablet in July 2019 or earlier and their last PrEP tablet in January 2019 or later.
From 17 May to 1 July 2019, 2,389 participants recruited through the iWantPrEPNow mailing list, social media and Grindr completed the survey. Compared with previous survey years [1] , the addition of recruitment through Grindr was new for 2019 (26%; n = 627); sampling changes could have affected observed behaviour differences compared with previous years. Those accessing the survey through Grindr had similar demographics to the total survey sample, except that fewer were living in England (88%; 554/627) and London (32%; 202/627). Participants were eligible for the survey if they were living in the UK and had tried to access or used PrEP since January 2017. Almost all (94%; n = 2,242) identified as exclusively gay and/ or bisexual men and the majority (85%; n = 2,041) reported white ethnicity (Table 1) . Half of respondents were aged 25-39 years (50%; n = 1,202). The majority (94%; n = 2,241) were living in England, while 3% (n = 73) were living in Scotland, 2% (n = 41) in Wales and 1% (n = 24) in Northern Ireland. Of participants, 78% (n = 1,856) had used PrEP since January 2017 and 94% (n = 1,742) of these were current PrEP users. Of respondents, 114 reported using PrEP since January 2017, but were not current users.
Sourcing, experiences and prevalence of PrEP users
Among current users, 62% (1,081/1,742) last sourced PrEP through a trial or programme, including 55% (949/1,742) through the English Impact trial and the remaining either through another trial or a sexual health clinic in Scotland, Wales or Northern Ireland, while 37% (638/1,742) last sourced privately, either through online purchase, buying privately from a clinic, through a friend/re-seller, using PEP as PrEP or obtaining while travelling abroad (Table 2) . A small proportion (16%) reported sharing or selling PrEP, most (61%) having originally sourced it online. Of current PrEP users, 75% took PrEP daily and 25% opted for other dosing regimens. The majority (75%) reported PrEP having only had a positive effect on their life (Box), although 17% reported feeling they had been treated differently while using PrEP, most commonly (42%) by acquaintances and/or strangers.
For each private PrEP user who was a non-regular clinic attendee, defined as reporting to have less than two HIV tests in the last 12 months, regardless of setting, there were two private users who were regular clinic attendees, defined as reporting having two or more HIV tests in the last 12 months at a sexual health clinic, and five trial/programme PrEP users ( Figure) . Using this 1:2:5 ratio, the upper limit of UK PrEP users is estimated to be one-seventh more than the numbers being monitored in clinics.
Sexual behaviour and sexual health
Condomless sex in the past 6 months was reported by 96% of current PrEP users, with a third of these reporting more than ten condomless sex partners (Table 1) . Almost a half (45%) reported that either none of these partners were on HIV treatment or PrEP or that they were unsure. In the past year, 63% reported using drugs just before or during sex and 42% reported chemsex. 
Challenges accessing pre-exposure prophylaxis (PrEP)
One in five (22%; 533/2,389) participants reported trying unsuccessfully to obtain PrEP since January 2017. Most (72%) tried to source through the Impact trial and over a quarter (27%) from online retailers ( Table  2 ). Compared with current users, a higher proportion of those unable to access PrEP were aged under 30 years (30% vs 18%), reported bisexual sexual orientation (14% vs 6%) and accessed the survey through other means, including Grindr (45% vs 26%) ( Table 1) . Rates of condomless sex were also high (82%) among those unable to access PrEP and 13% reported more than ten condomless sex partners. Half reported being unsure or that none of these partners were on HIV treatment or PrEP, and 50% reported using drugs just before or during sex in the past year.
Only 42% of non-users reported feeling satisfied with their sex life, compared with 70% of current PrEP users and smaller proportions of non-users reported chemsex in the past year compared with PrEP current users (16% vs 42%).
Discussion
Since 2015, steady declines in new HIV diagnoses have been observed among UK GBM [2, 3] . This followed the steady scale up of HIV testing over the past decade, the shortening of time to treatment initiation and the recent increase in PrEP use [4] [5] [6] [7] [8] . There were around 12,700 people accessing PrEP across England, Wales and Scotland through health service trials and programmes at the end of 2018 [6] [7] [8] . From our ratio of users sourcing through a trial/programme and privately ( Figure) , we estimate up to 7,600 others are sourcing PrEP privately. Of concern, we show that half of individuals sourcing PrEP privately are not undergoing baseline and ongoing renal function assessments, despite the majority being regular clinic attendees.
Our findings confirm that current PrEP users are at high-risk of exposure to HIV; the majority reported condomless sex with multiple partners and sexualised drug use, and many also reported condomless sex with partners of unknown HIV status or HIV treatment or PrEP status. The high STI rates reported in current PrEP users in this survey are consistent with recent reports in other countries [9, 10] and may reflect more frequent testing. Services providing PrEP should consider how they can mitigate STI risk through integrating PrEP Box Examples of current PrEP users' comments on the positive effects of PrEP on their lives and how they felt they were treated differently, PrEP user survey, United Kingdom, 2019
Positive effect on life from PrEP comments: provision with STI screening and treatment to enhance STI control [11] . A high proportion of current users reported taking daily PrEP despite previous published evidence that event-based oral PrEP is highly effective in preventing HIV [12] [13] [14] . PrEP had a strong positive effect on the lives of users and the majority were satisfied with their sex life.
Although PrEP is highly effective for HIV prevention, PrEP availability and scale-up across Europe has been slow and uneven to date, and the 'gap' between self-reported use and expressed need is large across European countries [15] . Additionally, our survey highlights high demand for PrEP and a larger PrEP 'gap' than expected, with around one in five individuals in need of PrEP but unable or unsure of how to access publicly funded PrEP. Many of them were at high risk of HIV and would have benefited from PrEP and the proportion unable to access PrEP is similar to findings from the PrEP user survey conducted in the previous year [1] , despite recent increases in the number of Impact trial places. However, this survey asked about experiences since January 2017 so the finding may be an expression of intermittent capping of trial places and capacity strains at trial clinics [8] . As other European countries are implementing pilot PrEP programmes or localised schemes, this report illustrates the value of estimating the true scale of PrEP need. c Privately sourcing PrEP users defined as PrEP users who last sourced PrEP either through online purchase, buying privately from a clinic, through a friend/re-seller, using PEP as PrEP or obtaining while travelling abroad.
d Regular clinic attendee defined as reporting having two or more HIV tests in the last 12 months at a sexual health clinic.
e Non-regular clinic attendee defined as reporting to have less than two HIV tests in the last 12 months, regardless of setting.
Finally, while knowledge of PrEP among UK GBM is among the highest in Europe [16] , a small but appreciable number of users reported a knowledge gap among healthcare providers, including negative judgements. Greater awareness among health professionals is required to ensure these experiences do not undermine access or adherence to PrEP.
